SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

Share Price is delayed by 15 minutes
Get Live Data
9.50    0.00 (0.00%)
Bid:
9.00
Ask:
10.00
Spread: 1.00 (11.111%)
Market Cap: £5.77m
PEG Live PriceLast checked at - London Stock Exchange

Intraday Petards Share Chart

Proposed Loan Note Conversion

23 Nov 2017 12:04

RNS Number : 3713X
Petards Group PLC
23 November 2017
 

23 November 2017

 

 

PETARDS GROUP PLC

AIM: PEG

("Petards" or the "Group")

 

Proposed Conversion of Loan Notes

Petards, the AIM quoted developer of advanced security and surveillance systems is pleased to announce that it will be posting a circular to Noteholders tomorrow convening a general meeting of Noteholders at which approval for the conversion of the Loan Notes into New Ordinary Shares will be sought.

Approval of the Loan Note Conversion would result in the Company issuing 18,498,400 New Ordinary Shares in exchange for all of the Company's outstanding £1,479,872 Loan Notes in issue.

All capitalised terms in this announcement are as defined in the Circular to Noteholders to which will be available on the Company's website: www.petards.com.

 

1. Background to and reasons for Modification of Noteholder Rights

The Loan Notes were issued in 2013 in connection with the Company's acquisition of the entire share capital of Water Hall Group plc. The Loan Notes are unsecured and are convertible into New Ordinary Shares at a price of £0.08 per New Ordinary Share. Since the Loan Notes were issued, the closing mid-market price of the Ordinary Shares has been consistently above £0.08. As at close of business on 23 November 2017, the mid-market price of the Ordinary Shares was £0.225.

At the present time the Company requires its cash reserves to finance its on-going working capital and investment activities. The Loan Notes mature in September 2018 and the Board does not wish to enter 2018 with the outstanding Loan Notes of £1,479,872 showing as current liabilities as it believes this may have an adverse effect on the perception of the Company from both a commercial and investment perspective. Therefore the Company is seeking the approval of Noteholders to convert all outstanding Loan Notes in issue into Ordinary Shares prior to the end of the current financial year.

The Board believes this to be in the best interests of the Company.

 

2. Loan Note Conversion

Pursuant to the Loan Note Instrument, a meeting of Noteholders has the power, exercisable by Special Resolution, to sanction any abrogation, modification or compromise of the Noteholders' rights which has been approved by the Company in accordance with the Loan Note Instrument. Accordingly the Resolution is being proposed at the Noteholder Meeting to approve the Modification of Noteholder Rights.

If the Resolution is approved by the Noteholders:

(a) New Ordinary Shares (rounded down to the nearest whole number of New Ordinary Shares) will be allotted fully paid to each Noteholder on the register of Noteholders on the Record Date in exchange for and in satisfaction of the whole of the principal amount of Loan Notes held by that Noteholder at the rate of one New Ordinary Share for each £0.08 in nominal amount of Loan Notes held by that Noteholder;

 

(b) an amount equal to all interest accrued but unpaid up to and including the Conversion Date in respect of the Loan Notes will be paid to each Noteholder; and

 

(c) no further action is required by Noteholders in relation to the Loan Note Conversion and the Resolution shall be binding on all Noteholders whether or not they are present at the Noteholder Meeting.

The Loan Note Conversion will take effect on 15 December 2017.

The New Ordinary Shares issued and allotted pursuant to the Loan Note Conversion shall rank pari passu with all other Ordinary Shares of the Company in issue on the date of the Loan Note Conversion.

Application will be made to the London Stock Exchange for all of the New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will take effect on 15 December 2017.

 

3. The Noteholder Meeting

The Circular will contain a notice convening the Noteholder Meeting to be held on 14 December 2017 at the offices of Simmons & Simmons LLP, CityPoint, One Ropemaker Street, London EC2Y 9SS at 11.30 a.m. at which the Resolution will be proposed as a Special Resolution.

 

4. Undertakings to vote at the Noteholder Meeting

As at the latest practicable date prior to the publication of the document (being close of business on 21 November 2017), each of El Khereiji Financial Company WLL, Rashid Abdullah, Water Hall Group PLC, Joan Margaret Abdullah and Osman Abdullah (who together hold legally or beneficially approximately 49.84% in nominal amount of the outstanding Loan Notes) have irrevocably undertaken to vote in favour of the Resolution to be proposed at the Noteholder Meeting.

 

TIMETABLE OF PRINCIPAL EVENTS

 

 

Publication of Noteholder Circular

24 November 2017

Latest time and date for receipt of Form of Proxy

11.00 a.m. on 12 December 2017

Noteholder Meeting

11.00 a.m. on 14 December 2017

Announcement of result of the Noteholder Meeting

14 December 2017

Record Date

6.00 p.m. on 14 December 2017

Admission and commencement of dealings of the New Ordinary Shares

 8.00 a.m. on 15 December 2017

 

**ENDS**

 

 

Contacts:

 

 

Petards Group plc

www.petards.com

 

Raschid Abdullah, Chairman

Mb: 07768 905 004

 

 

WH Ireland Limited, Nomad and Joint Broker

www.whirelandcb.com

 

Mike Coe / Ed Allsopp

Tel: 0117 945 3470

 

 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

 

Tel: 020 3764 2341

claire.noyce@hybridan.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CONBDBDBGGDBGRX
Date   Source Headline
20th May 202612:07 pmRNSResult of AGM
20th May 20267:00 amRNS-RContract Win
23rd Apr 20267:00 amRNSPosting of Annual Report and Notice of AGM
15th Apr 20267:01 amRNSDirector Appointment
15th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
27th Mar 20267:00 amRNSContract Wins
13th Feb 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSGrant of Share Options
5th Feb 20267:00 amRNSTrading Update
15th Dec 20257:00 amRNS-RDefence Order
2nd Dec 20259:00 amRNSNew Defence Contract Award
21st Nov 20257:00 amRNSContract extension
12th Nov 20254:41 pmRNSHolding(s) in Company
27th Oct 20259:00 amRNSRail Order Win
18th Sep 20257:00 amRNSInterim results
12th Sep 202510:51 amRNSNotice of Interim Results
12th Aug 20257:00 amRNS-RContract Win
6th Aug 202512:09 pmRNSResult of AGM
5th Aug 20257:00 amRNSMulti-year framework agreement renewal
29th Jul 20257:00 amRNS-RContract Renewal
30th Jun 20254:15 pmRNSPosting of Annual Report and Notice of AGM
24th Jun 20257:00 amRNS-RSaaS licensing renewal
23rd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
10th Jun 202512:17 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNS-RContract Win
28th May 20259:26 amRNS-RPetards Rail wins Alstom CSR Award
19th Mar 20258:39 amRNS-R‘Made in the North East’ Awards 2025
20th Feb 20257:00 amRNS-RContract Win
6th Feb 20253:33 pmRNSDirector/PDMR Shareholding
4th Feb 20254:49 pmRNSHolding(s) in Company
4th Feb 20254:45 pmRNSDirector/PDMR Shareholding
4th Feb 20259:33 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSTrading Update
20th Jan 20257:00 amRNSDirectorate Change
14th Jan 20257:00 amRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
25th Sep 20247:00 amRNSContract Win
24th Sep 202412:28 pmRNSContract Win
3rd Sep 20247:00 amRNSContract Wins
23rd Aug 20241:35 pmRNSContract Win
25th Jul 202411:33 amRNSResult of AGM
15th Jul 20247:00 amRNSChange of Adviser
24th Jun 20244:45 pmRNSPosting of Annual Report and Notice of AGM
14th Jun 20247:00 amRNSCompletion of Acquisition
13th Jun 20247:01 amRNSAcquisition
13th Jun 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSContract Win
14th Feb 20247:00 amRNSContract Extension
30th Jan 20247:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.